000 01530 a2200397 4500
005 20250514080114.0
264 0 _c20031031
008 200310s 0 0 eng d
022 _a0006-291X
024 7 _a10.1016/j.bbrc.2003.08.024
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuxbury, Mark S
245 0 0 _aGhrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness.
_h[electronic resource]
260 _bBiochemical and biophysical research communications
_cSep 2003
300 _a464-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenocarcinoma
_xcomplications
650 0 4 _aAndrostadienes
_xpharmacology
650 0 4 _aCachexia
_xdrug therapy
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aGhrelin
650 0 4 _aNeoplasm Invasiveness
650 0 4 _aPancreatic Neoplasms
_xcomplications
650 0 4 _aPeptide Hormones
_xpharmacology
650 0 4 _aTumor Cells, Cultured
_xdrug effects
650 0 4 _aWortmannin
700 1 _aWaseem, Talat
700 1 _aIto, Hiromichi
700 1 _aRobinson, Malcolm K
700 1 _aZinner, Michael J
700 1 _aAshley, Stanley W
700 1 _aWhang, Edward E
773 0 _tBiochemical and biophysical research communications
_gvol. 309
_gno. 2
_gp. 464-8
856 4 0 _uhttps://doi.org/10.1016/j.bbrc.2003.08.024
_zAvailable from publisher's website
999 _c12720605
_d12720605